Tsunedomi Ryoichi

Affiliate Master Yamaguchi University

A phase II study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

Journal of translational medicine Volume 12 Issue 1 Page 108-

published_at 2014-04-30

Title

A phase II study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study)

Creators Hazama Shoichi

Creators Nakamura Yusuke

Creators Tanaka Hiroaki

Creators Hirakawa Kosei

Creators Tahara Ko

Creators Shimizu Ryoichi

Creators Ozasa Hiroaki

Creators Etoh Ryuichi

Creators Sugiura Fumiaki

Creators Okuno Kiyotaka

Creators Furuya Takumi

Creators Nishimura Taku

Creators Sakata Koichiro

Creators Yoshimatsu Kazuhiko

Creators Takenouchi Hiroko

Creators Tsunedomi Ryouichi

Creators Inoue Yuka

Creators Kandkiyo Shinsuke

Affiliate Master Yamaguchi University

[kakenhi]15501 grid.268397.1

Creators Shindo Yoshitaro

Creators Suzuki Nobuaki

Creators Yoshino Shigefumi

Creators Shinozaki Hirokazu

Creators Kamiya Akira

Creators Furukawa Hiroyuki

Creators Yamanaka Takeharu

Creators Fujita Tomonobu

Creators Kawakami Yutaka

Creators Oka Masaaki

Creator Keywords

Peptide vaccine Peptide cocktail Colorectal cancer Phase II study FOLFOX Chemotherapy

Languages eng

Resource Type journal article

Publishers BioMed Central

Date Issued 2014-04-30

File Version Not Applicable (or Unknown)

Access Rights metadata only access

Relations

[ISSN]1479-5876

[NCID]AA12051092

[PMID]info:pmid/24884643

info:doi/10.1186/1479-5876-12-108

[isVersionOf] [URI]http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=214&action=archive

Schools 大学院医学系研究科（医学）医学部附属病院